Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer

NCT02317016 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

PROCEDURE: Pharmacokinetic sampling - AZD9291
DRUG: AZD9291 tablet dosing
DRUG: Rosuvastatin
PROCEDURE: Pharmacokinetic sampling - rosuvastatin
PROCEDURE: Pharmacokinetic sampling - AZ5140 and AZ7550

Sponsor

AstraZeneca